Answers are grounded in this paper and cite their sources.
Background: Systemic lupus erythematosus (SLE)-associated thrombocytopenia in pregnancy is a rare condition associated with potential harm to the mother, the fetus, and/or newborn, if the thrombocytopenia is severe (<50,000/mm 3 ). Controversy persists regarding the role and the timing of splenectomy in patients with SLE-associated refractory immune thrombocytopenia in pregnancy. This report describes the use of splenectomy at the time of the cesarean section (CS) in a patient with refractory SLE-associated thrombocytopenia.
No takes yet. Share an insight, caveat, or question.
Martinelli et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: